anipharmaceuticals.com (ANIP): O‘sish sur’atiga tuzatilgan narx-foyda
ANI Pharmaceuticals kompaniyasining sof foydasi surunkiz patologiyalarni davolashda qo'llaniladigan nisha generik dori vositalariga bo'lgan barqaror talabga asoslangan. Moslashtirilgan PEG koeffitsiyenti ushbu jarayonning dinamikasini aniq ko'rsatadi, 0.53 qiymati esa eng so'nggi metrika qiymatini aks ettiradi. Aralash narxlar siyosati ommaviy bozor chegirmalarini noyob dori vositalari uchun premium narxlar bilan birlashtiradi, bu esa sektorning defensiv xususiyatlari bilan birgalikda retsessiya davrida biznes barqarorligini ta'minlaydi.
ANI Pharmaceuticals (ANIP) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati ANI Pharmaceuticals|ANIP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati anipharmaceuticals.com|ANIP - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar ANI Pharma|ANIP - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi ANI Pharmaceuticals|Oraliq qoplama koeffitsiyenti anipharmaceuticals.com
- foyda va bozor koeffitsiyentlari statistikasi:
ANIP - Sof daromad|Kutilayotgan sof daromad ANI Pharmaceuticals|ANIP - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati ANI Pharmaceuticals Corp|ANIP - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati ANI Pharma|ANIP - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) ANI Pharmaceuticals|ANIP - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi anipharmaceuticals.com|ANIP - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi ANI Pharmaceuticals
Kompaniyaning umumiy tahlili:ANIP ANI Pharmaceuticals Inc
P/E ko'rsatkichining o'sish tendentsiyasini tahlil qilish ANI Pharmaceuticals (ANIP) ekotizimining kamyob kasalliklarni davolash samaradorligini va uning yopiq terapevtik zanjirini baholash imkonini beradi. Ushbu metrika bozorning foyda ko'paytiruvchisini uning o'sish sur'ati bilan solishtiradi, bunda birdan past qiymat aktivning biznes kengayishiga nisbatan qadrsizlanganligini anglatadi, bu esa kompaniyaning yuqori fundamental barqarorligi va xavfsizlik zaxirasini tasdiqlaydi.
ANI Pharmaceuticals raqobatchilari
HLN (Haleon PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Kenvue Corp KVUE|Verona Pharma Inc. (VRNA) - O‘sish sur’atiga tuzatilgan narx-foyda|MENS: Narx-foyda va o‘sish multiplikatori|ligand.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|AMRX: PEG multiplikatori|Perrigo Company PLC - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|ALVO (Alvotech Corp) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Liquidia Inc. LQDA|Narxning foydaga va o‘sish sur’atiga nisbati Galapagos NV (GLPG)|MNKD (mannkindcorp.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori AMPH (Amphastar Pharmaceuticals, Inc.)|PEG multiplikatori Pacira Pharmaceuticals PCRX|SPRY - Narxning foydaga va o‘sish sur’atiga nisbati|TBPH (Theravance Corp) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|AQST: PEG multiplikatori|SCPH - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori TECX|TNXP: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati China SXT Pharmaceuticals (SXTC)|EPRX: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori BHST (BioHarvest Sciences)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti EXOZ|Oramed Pharma - PEG multiplikatori|ENTX - PEG multiplikatori|MindWalk (HYFT) - Narxning foydaga va o‘sish sur’atiga nisbati|ABVC BioPharma, Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Cumberland Pharmaceuticals|Narx-foyda va o‘sish multiplikatori quantumbiopharma.com (QNTM)|PEG multiplikatori FGEN|PEG multiplikatori Telomir Pharmaceuticals Inc (TELO)|PEG multiplikatori RANI (Rani Therapeutics Holdings, Inc.)|SNYR - Narx-foyda va o‘sish multiplikatori|Rallybio Corp. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Lexaria Bioscience|PULM (Pulmatrix) - Narx-foyda va o‘sish multiplikatori|Pheton Holdings (PTHL) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori APM|LYRA (Lyra Therapeutics Inc) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori IBO|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati tnfpharma.com|PEG multiplikatori YCBD (cbdMD)|PRFX - Narx-foyda va o‘sish multiplikatori|Auris Medical - PEG multiplikatori|LIPO - PEG multiplikatori|OptiNose, Inc. (OPTN) - Narxning foydaga va o‘sish sur’atiga nisbati|PIRS (pieris.com) - Narxning foydaga va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Procaps|Petros Pharmaceuticals Inc (PTPI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori QLI|PEG multiplikatori ACELYRIN Inc. (SLRN)|Narxning foydaga va o‘sish sur’atiga nisbati TFF Pharmaceuticals TFFP
